Avior Wealth Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1
Closed -$29 2453
2024
Q1
$29 Buy
+1
New +$26 ﹤0.01% 3612
2023
Q4
Sell
-10
Closed -$608 1537
2023
Q3
$608 Buy
+10
New +$702 ﹤0.01% 1477
2021
Q4
Sell
-2
Closed 1094
2021
Q3
$0 Hold
2
﹤0.01% 1058
2021
Q2
$0 Hold
2
﹤0.01% 1033
2021
Q1
$0 Hold
2
﹤0.01% 1009
2020
Q4
$1K Hold
2
﹤0.01% 902
2020
Q3
$1K Hold
2
﹤0.01% 853
2020
Q2
$1K Hold
2
﹤0.01% 827
2020
Q1
$1K Hold
2
﹤0.01% 708
2019
Q4
$2K Hold
2
﹤0.01% 710
2019
Q3
$2K Hold
2
﹤0.01% 671
2019
Q2
$3K Hold
2
﹤0.01% 693
2019
Q1
$3K Hold
2
﹤0.01% 591
2018
Q4
$2K Hold
2
﹤0.01% 662
2018
Q3
$4K Hold
2
﹤0.01% 639
2018
Q2
$4K Hold
2
﹤0.01% 661
2018
Q1
$4K Hold
2
﹤0.01% 639
2017
Q4
$4K Buy
+2
New +$4.06K ﹤0.01% 656

Other funds holding BLUE

Avior Wealth Management's BLUE Position: Q2 2024 in Review

Avior Wealth Management sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 1 share — an estimated $29 sold.

Avior Wealth Management first reported a position in BLUE in Q4 2017 and held it in 18 quarters. The position peaked at $4K in Q3 2018. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Avior Wealth Management reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 1 bluebird bio share in Q2 2024, an estimated $29.
  • Avior Wealth Management first reported a position in bluebird bio in Q4 2017 and held it in 18 quarters.
  • Avior Wealth Management's bluebird bio position peaked at $4K in Q3 2018.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.